SCA
MDGL icon

Secor Capital Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History

Secor Capital Advisors’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-685
Closed -$42K – 596
2015
Q3 		$42K Sell
685
-317
-32% -$22.9K 0.01% 481
2015
Q2 		$78K Hold
1,002
– – 0.03% 404
2015
Q1 		$68K Hold
1,002
– – 0.03% 438
2014
Q4 		$93K Buy
+1,002
New +$104K 0.04% 373

Other funds holding MDGL

CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Secor Capital Advisors's MDGL Position: Q4 2015 in Review

Secor Capital Advisors sold out of Madrigal Pharmaceuticals (MDGL) in Q4 2015, closing a stake of 685 shares — an estimated $42K sold.

Secor Capital Advisors first reported a position in MDGL in Q4 2014 and held it in 4 quarters. The position peaked at $93K in Q4 2014. 75 funds tracked by Wall St. Rank hold MDGL as of Q4 2015.

  • Secor Capital Advisors reported no remaining Madrigal Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • Secor Capital Advisors sold 685 Madrigal Pharmaceuticals shares in Q4 2015, an estimated $42K.
  • Secor Capital Advisors first reported a position in Madrigal Pharmaceuticals in Q4 2014 and held it in 4 quarters.
  • Secor Capital Advisors's Madrigal Pharmaceuticals position peaked at $93K in Q4 2014.
  • 75 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q4 2015.

Based on Secor Capital Advisors's 13F filing for Q4 2015, filed 8 Feb 2016.